Article info
PDFEconomic analysis
Cost-effectiveness analysis
Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment
- Correspondence to: Dr Laurence Klotz, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room MG 408, Toronto, ON, Canada M4N 3M5; laurence.klotz{at}sunnybrook.ca
Citation
Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment
Publication history
- First published August 29, 2013.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions